北米デジタル治療（DTx）市場 – 業界動向と2028年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare IT 北米デジタル治療（DTx）市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

北米デジタル治療（DTx）市場 – 業界動向と2028年までの予測

  • Healthcare IT
  • Published Report
  • Feb 2021
  • North America
  • 350 ページ
  • テーブル数: 61
  • 図の数: 36
Buy Now 今すぐ購入

>北米デジタルセラピー（DTx）市場、製品およびサービスタイプ別（ハードウェア製品、ソリューション/ソフトウェア、サービス）、アプリケーション別（治療/ケア関連アプリケーション、予防アプリケーション）、購入モード別（グループ購入組織、個人）、販売チャネル別（B2B、B2C）、国別（米国、カナダ、メキシコ）業界動向と2028年までの予測

北米デジタル治療（DTx）市場市場分析と洞察: 北米デジタル治療 (DTx) 市場

デジタル治療（DTx）市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に23.4％のCAGRで成長し、2028年までに106億3,936万米ドルに達すると分析しています。糖尿病、高血圧などの慢性疾患の罹患率の増加や政府機関による意識の高まりにより、デジタル治療（DTx）市場の成長が加速するでしょう。

デジタル治療 (DTx) は、証拠に基づく遠隔評価ソフトウェアを使用して患者に直接治療介入を行い、幅広い行動、精神、身体障害に対応、管理、回避します。これらは単独で使用されるか、薬剤、デバイス、またはその他の治療法と組み合わせて使用​​され、患者のケアと健康状態を最適化します。治療中のデジタル治療 (DTx) の特性の 1 つは、臨床的に安全で効果的であるとテストされた治療法への遠隔アクセスの増加です。

企業が製品ラインを拡大し、利益を得るために行う技術の進歩は、デジタル治療（DTx）市場の成長の原動力の1つです。デジタル治療（DTx）アプリに関連するプライバシーの懸念は、デジタル治療（DTx）市場の成長の抑制要因となる可能性があります。企業間のコラボレーションは市場の成長を助け、デジタル治療（DTx）市場にとっての機会となります。デジタル治療（DTx）の品質は、顧客により良い治療と適切なケアを提供するために維持される必要があるため、正しく行う必要がありますが、多くの場合ニーズが満たされないため、これはデジタル治療（DTx）市場にとって課題となります。   

デジタル治療 (DTx) 市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析とデジタル治療 (DTx) 市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

北米デジタル治療（DTx）市場デジタル治療（DTx）市場の範囲と市場規模

The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since there are number of smart phone users being increased.
  • On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since it provides a good treatment and improve the life style of the people.   
  • On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and preferring them in the pandemic situation.
  • On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers.

North America Digital Therapeutic (DTx) Market Country Level Analysis

North America digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.  

The countries covered in the North America digital therapeutic (DTx) market report are the U.S., Canada and Mexico.  

North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes. The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) products

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

メーカーによる戦略的取り組みがデジタル治療（DTx）市場のプレーヤーに新たな機会を生み出している

デジタル治療 (DTx) 市場では、各国のデジタル治療 (DTx) 製品販売の成長、デジタル治療 (DTx) の進歩の影響、デジタル治療 (DTx) 市場へのサポートに関する規制シナリオの変化など、詳細な市場分析も提供しています。データは 2011 年から 2019 年までの履歴期間について入手できます。

競争環境とデジタル治療（DTx）市場シェア分析

デジタル治療 (DTx) 市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供されている上記のデータ ポイントは、デジタル治療 (DTx) 市場に関連する会社の焦点にのみ関連しています。

北米デジタルセラピー（DTx）市場レポートで取り上げられている主要企業は、Fitbit、Inc.、Livongo、ResMed、Omada Health、Inc.、Noom、Inc.、Happify、Inc.、Welldoc、Inc.、SAMSUNG、ATENTIV、MANGO HEALTH、CogniFit、Kaia Health、Mindstrong Health、Smartpatient gmbh、Ayogo Health Inc.、Ginger、Better Therapeutics、Inc.、2Morrow Inc.、CANARY HEALTH、Click Therapeutics、Inc.、Cognoa、Pear Therapeutics、Inc.、Voluntis、Akili Interactive Labs、Inc.、その他の国内企業です。DBMRアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。

世界中の企業によって多くの製品の発売や契約も開始されており、デジタル治療 (DTx) 市場も加速しています。

例えば、

  • 2019年8月、ATENTIVは小児専門病院センターと提携しました。両者の協力関係は、プライマリケアの臨床医によるATENTIV myndの伝達のための最良の臨床慣行を活用した、統一された行動および基本治療オペレーティングシステムの共同開発で構成されています。この協力関係により、同社のブランド価値と製品の市場価値が向上します。

市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、デジタル治療 (DTx) 市場における企業市場が強化され、組織がデジタル治療 (DTx) の提供内容を改善するためのメリットももたらされます。   

 

 

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 NORTH AMERICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES

5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES

5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE

5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES

5.1.5 IMPROVED QUALITY OF LIFE

5.2 RESTRAINTS

5.2.1 PATIENT INFORMATION PRIVACY POLICIES

5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS

5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES

5.3 OPPORTUNITIES

5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS

5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES

5.3.3 PARTNERSHIP BETWEEN COMPANIES

5.3.4 EXPANSION AND LAUNCH OF PRODUCTS

5.3.5 EVENTS AND EXHIBITION

5.3.6 PHYSICIAN ADOPTION

5.4 CHALLENGES

5.4.1 CLINICAL VALIDATION

5.4.2 REGULATORY APPROVAL

5.4.3 PAYER REIMBURSEMENT

6 IMPACT OF COVID-19 ON NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

6.1 IMPACT ON DEMAND

6.2 IMPACT ON SUPPLY

6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19

6.4 CONCLUSION

7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE

7.1 OVERVIEW

7.2 SOLUTION/SOFTWARE

7.3 HARDWARE PRODUCTS

7.4 SERVICE

8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 TREATMENT/CARE-RELATED APPLIACTIONS

8.2.1 DIABETES

8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS

8.2.3 SMOKING CESSATION

8.2.4 CHRONIC RESPIRATORY DISEASES

8.2.5 MUSCULOSKELETAL DISORDER

8.2.6 CARDIOVASCULAR DISEASES

8.2.7 MEDICATION ADHERENCE

8.2.8 GASTROINTESTINAL DISORDERS

8.2.9 REHABILITATION AND PATIENT CARE

8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT

8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS

8.3 PREVENTIVE APPLICATIONS

8.3.1 PREDIABETES

8.3.2 OBESITY

8.3.3 NUTRITION

8.3.4 LIFESTYLE MANAGEMENT

8.3.5 OTHER PREVENTIVE APPLICATIONS

9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE

9.1 OVERVIEW

9.2 GROUP PURCHASE ORGANIZATION

9.2.1 SOLUTIONS/ SOFTWARE

9.2.2 HARDWARE PRODUCT

9.2.3 SERVICE

9.3 INDIVIDUAL

9.3.1 SOLUTIONS/ SOFTWARE

9.3.2 HARDWARE PRODUCT

9.3.3 SERVICE

10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL

10.1 OVERVIEW

10.2 B2B

10.2.1 PAYERS

10.2.2 EMPLOYERS

10.2.3 PHARMA COMPANIES

10.2.4 PROVIDERS

10.2.5 OTHER BUYERS

10.3 B2C

10.3.1 CAREGIVERS

10.3.2 PATIENTS

11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 SWOT

14 COMPANY PROFILE

14.1 FITBIT,INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 LIVONGO

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 RESMED

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 OMADA HEALTH, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 GINGER

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 SAMSUNG

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 MINDSTRONG HEALTH

14.7.1 COMPANY SNAPSHOT

14.7.2 SERVICE PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 2MORROW INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 AKILI INTERACTIVE LABS, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

 

14.1 ATENTIV

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 AYOGO HEALTH INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 BETTER THERAPEUTICS, INC

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 CANARY HEALTH

14.13.1 COMPANY SNAPSHOT

14.13.2 SOLUTION PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 CLICK THERAPEUTICS, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 COGNIFIT

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 COGNOA

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 GAIA AG

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 HAPPIFY, INC.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 KAIA HEALTH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MANGO HEALTH

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENTS

14.21 NATURAL CYCLES USA CORP

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 NOOM, INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENT

14.23 PEAR THERAPEUTICS, INC.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENTS

14.24 SMARTPATIENT GMBH

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 VOLUNTIS

14.25.1 COMPANY SNAPSHOT

14.25.2 REVENUE ANALYSIS

14.25.3 PRODUCT PORTFOLIO

14.25.4 RECENT DEVELOPMENTS

14.26 WELLDOC, INC.

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENTS

14.27 WELLTHY THERAPEUTICS PVT LTD

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表のリスト

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

TABLE 3 NORTH AMERICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))

TABLE 4 NORTH AMERICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)

TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)

TABLE 12 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)

TABLE 17 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 33 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 37 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 38 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 42 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 43 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 47 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 48 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 49 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 50 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 53 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 57 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 58 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

 

図表一覧

LIST OF FIGURES

FIGURE 1 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.

FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

FIGURE 15 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020

FIGURE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

FIGURE 17 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)

FIGURE 18 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020

FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)

FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020

FIGURE 24 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)

FIGURE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)

FIGURE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 27 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020

FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)

FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)

FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE

FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)

FIGURE 32 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)

FIGURE 33 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)

FIGURE 34 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)

FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)

 

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The North America Digital Therapeutic (DTx) Market will witness a 23.4% CAGR forecast by 2028.
The North America Digital Therapeutic (DTx) Market values at $10,639.36 million by 2028.
The countries covered in the North America digital therapeutic (DTx) market report are the U.S., Canada, and Mexico.
North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes.

関連ページを閲覧する

Banner